We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly, UnitedHealth Team Up on Pragmatic Study of COVID-19 Antibody Treatment
Eli Lilly, UnitedHealth Team Up on Pragmatic Study of COVID-19 Antibody Treatment
Eli Lilly and healthcare company UnitedHealth are working together to conduct a pragmatic study of the American pharma titan’s COVID-19 antibody treatment, bamlanivimab (LY-CoV555), a therapy that received Emergency Use Authorization (EUA) from the FDA nearly a month ago.